COMPANIES COVERED
Sanofi AventisDownload FREE Report Sample
Download Free sampleRoxatidine is a special H2-receptor antagonist, which is mostly prescribed for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. It is generally classified as an antacid, anti-reflux, or anti-ulcerant drug.
Roxatidine Market contains market size and forecasts of Roxatidine in global, including the following market information:
Global Roxatidine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Roxatidine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Roxatidine companies in 2021 (%)
The global Roxatidine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Roxatidine include Sanofi Aventis, Sihuan Pharmaceutical, Sun Pharmaceutical, Taj Pharmaceuticals, Shin Poong Pharmaceuticals and Sawai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Roxatidine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Roxatidine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Roxatidine Market Segment Percentages, by Type, 2021 (%)
Oral
Injectable
Global Roxatidine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Roxatidine Market Segment Percentages, by Application, 2021 (%)
Acidity
Heartburn
Intestinal Ulcers
Stomach Ulcers
Others
Global Roxatidine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Roxatidine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Roxatidine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Roxatidine revenues share in global market, 2021 (%)
Key companies Roxatidine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Roxatidine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Aventis
Sihuan Pharmaceutical
Sun Pharmaceutical
Taj Pharmaceuticals
Shin Poong Pharmaceuticals
Sawai Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
